In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...

Victoza is one of the first GLP-1 drugs — the class of wildly popular diabetes and obesity treatments that includes Ozempic ...

Next year, Jordan Brand is remixing a classic colorway of the Air Jordan 11 for its annual women's holiday release.

It's granted by the U.S. Patent and Trademark Office (PTO) and has a term of 14 to 20 years. Owning a patent gives you the right to stop someone else from making, using or selling your invention ...

“Clearly this is a space that we’re intending to go after,” said Sandoz CEO Richard Saynor, when asked about GLP-1s on its ...

How few? Just a mere 4% of all Hot 100 No. 1s dating to the chart’s launch on Aug. 4, 1958, have earned the achievement. In honor of the singles to claim the Hot 100’s top spot the longest ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's patent rights in nerve-stimulation technology. Samsung Electronics owes an ...

In the years since, the U.S. patent system has been a driving force behind continued economic growth and innovation. Today, however, that system is under threat. Fortunately, Congress is ...

Some GLP-1s, like Ozempic (semaglutide), tirzepatide (Mounjaro), and dulaglutide (Trulicity), are usually taken weekly. Others, like liraglutide (Saxenda, Victoza), are typically administered daily.

Schedule K-1s are usually issued by pass-through businesses or financial entities that don't directly pay corporate tax on their income but shift the tax liability (along with most of their income ...

Europe has one of the most diverse seed industries in the world. In Germany, the Netherlands and France alone, hundreds of ...

Two critical factors limit access to treatment: the high prices of new medicines, particularly those that are patent-protected, and the lack of medicines and vaccines to treat neglected diseases, a ...